Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.20

-5.5%

Nov 12 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (7731)	1/15/2003 12:01:59 PM
From: Icebrg	Read Replies (2) of 52153

>>If memory serves (it does not always serve well) the first death from gene therapy in Philadelphia involved a retrovirus.>> Not this time, unfortunately. At least not if it was Jesse Gelsinger's case you were thinking of. It was an adenovirus. Erik biosafety.ihe.be

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next